Janux Therapeutics, Inc. Profile Avatar - Palmy Investing

Janux Therapeutics, Inc.

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are i…

Biotechnology
US, La Jolla [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of JANX's Analysis
CIK: 1817713 CUSIP: 47103J105 ISIN: US47103J1051 LEI: - UEI: -
Secondary Listings
JANX has no secondary listings inside our databases.